Andrew B. Buletko

A Mobile Stroke Treatment Unit for Field Triage of Patients for Intraarterial Revascularization Therapy.

Favorable outcomes in intraarterial therapy (IAT) for acute ischemic stroke (AIS) are related to early vessel recanalization. The mobile stroke treatment unit (MSTU) is an on‐site, prehospital, treatment team, laboratory, and CT scanner that reduces time to treatment for intravenous thrombolysis and may also shorten time to IAT.

Reduction in time to treatment in prehospital telemedicine evaluation and thrombolysis

Objective: To compare the times to evaluation and thrombolytic treatment of patients treated with a telemedicine-enabled mobile stroke treatment unit (MSTU) vs those among patients brought to the emergency department (ED) via a traditional ambulance. Methods: We implemented a MSTU with telemedicine at our institution starting July 18, 2014. A vascular neurologist evaluated each patient via telemedicine and a neuroradiologist and vascular neurologist remotely assessed images obtained by the MSTU CT. Data were entered in a prospective registry. The evaluation and treatment of the first 100 MSTU patients (July 18, 2014–November 1, 2014) was compared to a control group of 53 patients brought to the ED via a traditional ambulance in 2014. Times were expressed as medians with their interquartile ranges. Results: Patient and stroke severity characteristics were similar between 100 MSTU and 53 ED control patients (initial NIH Stroke Scale score 6 vs 7, p = 0.679). There was a significant reduction of median alarm-to-CT scan completion times (33 minutes MSTU vs 56 minutes controls, p < 0.0001), median alarm-to-thrombolysis times (55.5 minutes MSTU vs 94 minutes controls, p < 0.0001), median door-to-thrombolysis times (31.5 minutes MSTU vs 58 minutes controls, p = 0.0012), and symptom-onset-to-thrombolysis times (97 minutes MSTU vs 122.5 minutes controls, p = 0.0485). Sixteen patients evaluated on MSTU received thrombolysis, 25% of whom received it within 60 minutes of symptom onset. Conclusion: Compared with the traditional ambulance model, telemedicine-enabled ambulance-based thrombolysis resulted in significantly decreased time to imaging and treatment.

Acral gangrene as a presentation of non-uremic calciphylaxis

We are describing a case of 55-year-old obese female with significant history of uncontrolled rheumatoid arthritis, who recently had decreased her immune-suppression medications. She presented with extensive acral gangrene involving multiple fingers and toes. Clinical picture and laboratory findings were suggestive of vasculitis; however, skin biopsy established diagnosis of calciphylaxis, in settings of normal kidney function. Patient was treated with sodium thiosulfate with gradual improvement in her skin lesions.

Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage

Objective To determine the incidence and predictors of acute cerebral ischemia and neurologic deterioration in intracerebral hemorrhage (ICH) patients after an institutional protocol change in systolic blood pressure (SBP) target from <160 to <140 mm Hg. Methods We retrospectively compared persons admitted with primary ICH before and after a protocol change in SBP target from <160 to <140 mm Hg. The primary outcomes were presence of acute cerebral ischemia on MRI completed within 2 weeks of ICH and acute neurologic deterioration. Results Of 286 persons with primary ICH, 119 underwent MRI and met inclusion criteria. Sixty-two had a target SBP <160 mm Hg (group 1) and 57 had a target SBP <140 mm Hg (group 2). There were no differences between the 2 groups in baseline clinical and radiographic characteristics, but over the first 24 hours of hospitalization, group 2 had lower mean SBP (134 vs 143 mm Hg, p < 0.001) and lower minimum SBP over 72 hours (106 vs 112 mm Hg, p = 0.02). Acute cerebral ischemia was more frequent in group 2 than in group 1 (32% vs 16%; p = 0.047) as was acute neurologic deterioration (19% vs 5%; p = 0.022). A minimum SBP ≤120 mm Hg over 72 hours was associated with cerebral ischemia, while no patient with a minimum SBP ≥130 mm Hg had cerebral ischemia. Acute cerebral ischemia was significantly associated with worse discharge NIH Stroke Scale score, while SBP target was not. Conclusions Intensive lowering of SBP <140 mm Hg in acute ICH, particularly allowing SBP <120 mm Hg, is associated with increased remote cerebral ischemic lesions and acute neurologic deterioration.

Magnetic Resonance Imaging Susceptibility-Weighted Imaging Lesion and Contrast Enhancement May Represent Infectious Intracranial Aneurysm in Infective Endocarditis

Background: Infectious intracranial aneurysm (IIA) can complicate infective endocarditis (IE). We aimed to describe the magnetic resonance imaging (MRI) characteristics of IIA. Methods: We reviewed IIAs among 116 consecutive patients with active IE by conducting a neurological evaluation at a single tertiary referral center from January 2015 to July 2016. MRIs and digital cerebral angiograms (DSA) were reviewed to identify MRI characteristics of IIAs. MRI susceptibility weighted imaging (SWI) was performed to collect data on cerebral microbleeds (CMBs) and sulcal SWI lesions. Results: Out of 116 persons, 74 (63.8%) underwent DSA. IIAs were identified in 13 (17.6% of DSA, 11.2% of entire cohort) and 10 patients with aneurysms underwent MRI with SWI sequence. Nine (90%) out of 10 persons with IIAs had CMB >5 mm or sulcal lesions in SWI (9 in sulci, 6 in parenchyma, and 5 in both). Five out of 8 persons who underwent MRI brain with contrast had enhancement within the SWI lesions. In a multivariate logistic regression analysis, both sulcal SWI lesions (p < 0.001, OR 69, 95% CI 7.8-610) and contrast enhancement (p = 0.007, OR 16.5, 95% CI 2.3-121) were found to be significant predictors of the presence of IIAs. Conclusions: In the individuals with IE who underwent DSA and MRI, we found that neuroimaging characteristics, such as sulcal SWI lesion with or without contrast enhancement, are associated with the presence of IIA

A Case of Dural Arteriovenous Fistula Mimicking a Cerebellar Tumor

A 49-year-old healthy male presented to his local hospital with intractable headache, nausea, and ataxia. Initial gadolinium-enhanced magnetic resonance imaging (MRI) of the brain revealed an enhancing cerebellar mass lesion with vasogenic edema (Figure 1). A computed tomography scan of the chest, abdomen, and pelvis was unremarkable. He underwent biopsy for a presumptive diagnosis of a cerebellar tumor. The pathology showed nonspecific reactive changes without inflammation or malignant cells. An extensive infectious and autoimmune serological workup was negative and the patient was placed on long-term steroids and his symptoms improved. Vascular imaging was not performed at this time. Six months later, his symptoms recurred with nausea and unsteady gait and presented to our center. His neurological examination was unremarkable except for right gaze-evoked nystagmus. Repeat MRI of the brain again showed a cerebellar mass lesion with leptomeningeal enhancement. The MRI of the spine was unremarkable. Cerebrospinal fluid (CSF) evaluation revealed 430 red blood cells/mL, 12 white blood cells/mL (88% lymphocytes), 74 mg/dL protein, and 67 mg/dL glucose (103 mg/dL serum glucose). Extensive serum and CSF infectious, inflammatory, and malignancy workup was negative including testing for human immunodeficiency virus, herpes simplex virus-1/2, JC virus, varicella-zoster virus, Epstein–Barr virus, syphilis, cryptococcus, enterovirus. In addition, neuromyelitis optica antibody, paraneoplastic antibodies, cytology, IgG index, oligoclonal bands, and CSF bacterial and fungal cultures were negative. A positron emission tomography scan of the whole body including the brain was negative. A cerebral angiogram revealed an early and slow right cerebellar draining vein, consistent with a dural arteriovenous fistula (DAVF; Figure 2). The patient had a microsurgical ligation of the arterialized vein, which was exiting the tentorium and travelling along the superior

Teaching Neuro Images : Rare cause of Horner syndrome in Loeys-Dietz syndrome

A 36-year-old woman with Loeys-Dietz syndrome presented with left eye ptosis, anisocoria, and shoulder pain. The diagnosis of left-sided Horner syndrome was made (figure 1). The patient had a known left subclavian artery aneurysm with percutaneous stent graft placement. CT angiography revealed a large left subclavian aneurysm sac, consistent with endoleak type I (figure 2). Horner syndrome and shoulder pain improved following common carotid to axillary artery bypass in addition to thoracic endovascular aortic repair surgery.

Neurologic Injuries in Noncontact Sports

Noncontact sports are associated with a variety of neurologic injuries. Concussion, vascular injury (arterial dissection), and spinal cord trauma may be less common in noncontact sports, but require special attention from the sports neurologist. Complex regional pain disorders, muscle injury from repetitive use, dystonia, heat exposure, and vascular disorders (patent foramen ovale), occur with similar frequency in noncontact and contact sports. Management of athletes with these conditions requires an understanding of the neurologic consequences of these disorders, the risk of injury with return to play, and consideration for the benefits of exercise in health restoration and disease prevention.